Literature DB >> 12454157

Clinical Escherichia coli strains carrying stx genes: stx variants and stx-positive virulence profiles.

Marjut Eklund1, Kirsikka Leino, Anja Siitonen.   

Abstract

Altogether, 173 Shiga toxin-producing Escherichia coli (STEC) serotype O157 (n = 111) and non-O157 (n = 62) isolates from 170 subjects were screened by PCR-restriction fragment length polymorphism for eight different stx genes. The results were compiled according to serotypes, phage types of O157, production of Stx toxin and enterohemolysin, and the presence of eae. The stx genes occurred in 11 combinations; the most common were stx(2) with stx(2c) (42%), stx(2) alone (21%), and stx(1) alone (16%). Of the O157 strains, 64% carried stx(2) with stx(2c) versus 2% of the non-O157 strains (P < 0.001). In the non-O157 strains, the prevailing gene was stx(1) (99% versus 1% in O157 strains; P < 0.001). In addition, one strain (O Rough:H4:stx(2c)) which has not previously been described as associated with hemolytic-uremic syndrome (HUS) was found. Ten stx-positive virulence profiles were responsible for 71% of all STEC infections. Of these profiles, five accounted for 71% of the 21 strains isolated from 20 patients with HUS or thrombotic thrombocytopenic purpura (TTP). The strains having the virulence profile that caused mainly HUS or TTP or bloody diarrhea produced Stx with titers of >/=1:128 (90%) more commonly than did other strains (51%; P < 0.001). These strains were also more commonly enterohemolytic (98% versus 68% for other strains; P < 0.001) and possessed the eae gene (100%) more commonly than did other strains (74%; P < 0.001). A particular virulence profile, O157:H7:PT2:stx(2):stx(2c):eae:Ehly, was significantly more frequently associated with HUS and bloody diarrhea than were other profiles (P = 0.02) and also caused the deaths of two children. In this study, the risk factors for severe symptoms were an age of <5 years and infection by the strain of O157:H7:PT2 mentioned above.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12454157      PMCID: PMC154619          DOI: 10.1128/JCM.40.12.4585-4593.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  42 in total

1.  Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.

Authors:  Alexander W Friedrich; Martina Bielaszewska; Wen-Lan Zhang; Matthias Pulz; Thorsten Kuczius; Andrea Ammon; Helge Karch
Journal:  J Infect Dis       Date:  2001-12-14       Impact factor: 5.226

2.  Quorum sensing controls expression of the type III secretion gene transcription and protein secretion in enterohemorrhagic and enteropathogenic Escherichia coli.

Authors:  V Sperandio; J L Mellies; W Nguyen; S Shin; J B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

3.  Swimming-associated outbreak of Escherichia coli O157:H7.

Authors:  M Paunio; R Pebody; M Keskimäki; M Kokki; P Ruutu; S Oinonen; V Vuotari; A Siitonen; E Lahti; P Leinikki
Journal:  Epidemiol Infect       Date:  1999-02       Impact factor: 2.451

4.  The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients.

Authors:  S Dundas; W T Todd; A I Stewart; P S Murdoch; A K Chaudhuri; S J Hutchinson
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

5.  EPEC, EAEC and STEC in stool specimens: prevalence and molecular epidemiology of isolates.

Authors:  M Keskimäki; M Eklund; H Pesonen; T Heiskanen; A Siitonen
Journal:  Diagn Microbiol Infect Dis       Date:  2001-08       Impact factor: 2.803

Review 6.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

7.  Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France. The Société de Néphrologie Pédiatrique.

Authors:  B Decludt; P Bouvet; P Mariani-Kurkdjian; F Grimont; P A Grimont; B Hubert; C Loirat
Journal:  Epidemiol Infect       Date:  2000-04       Impact factor: 2.451

8.  Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans.

Authors:  P Boerlin; S A McEwen; F Boerlin-Petzold; J B Wilson; R P Johnson; C L Gyles
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Verocytotoxin-producing Escherichia coli in children with hemolytic uremic syndrome in the Czech Republic.

Authors:  M Bielaszewska; J Janda; K Blahová; J Feber; V Potuzník; A Soucková
Journal:  Clin Nephrol       Date:  1996-07       Impact factor: 0.975

Review 10.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

View more
  66 in total

1.  Strong association between shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndrome.

Authors:  D Werber; A Fruth; U Buchholz; R Prager; M H Kramer; A Ammon; H Tschäpe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-11-12       Impact factor: 3.267

2.  Non-O157 verotoxigenic Escherichia coli and beef: a Canadian perspective.

Authors:  Alexander Gill; Colin O Gill
Journal:  Can J Vet Res       Date:  2010-07       Impact factor: 1.310

Review 3.  A Toxic Environment: a Growing Understanding of How Microbial Communities Affect Escherichia coli O157:H7 Shiga Toxin Expression.

Authors:  Erin M Nawrocki; Hillary M Mosso; Edward G Dudley
Journal:  Appl Environ Microbiol       Date:  2020-11-24       Impact factor: 4.792

4.  Verotoxins in bovine and meat verotoxin-producing Escherichia coli isolates: type, number of variants, and relationship to cytotoxicity.

Authors:  Alejandra Krüger; Paula M A Lucchesi; Alberto E Parma
Journal:  Appl Environ Microbiol       Date:  2010-10-29       Impact factor: 4.792

5.  First-time isolation and characterization of a bacteriophage encoding the Shiga toxin 2c variant, which is globally spread in strains of Escherichia coli O157.

Authors:  Eckhard Strauch; Christoph Schaudinn; Lothar Beutin
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

6.  Subtyping method for Escherichia coli shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations.

Authors:  Søren Persson; Katharina E P Olsen; Steen Ethelberg; Flemming Scheutz
Journal:  J Clin Microbiol       Date:  2007-04-19       Impact factor: 5.948

7.  Enhanced surveillance of non-O157 verotoxin-producing Escherichia coli in human stool samples from Manitoba.

Authors:  Laura H Thompson; Sandra Giercke; Carole Beaudoin; David Woodward; John L Wylie
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-11       Impact factor: 2.471

8.  Rapid and sensitive detection of Shiga toxin-producing Escherichia coli from nonenriched stool specimens by real-time PCR in comparison to enzyme immunoassay and culture.

Authors:  Thomas E Grys; Lynne M Sloan; Jon E Rosenblatt; Robin Patel
Journal:  J Clin Microbiol       Date:  2009-05-13       Impact factor: 5.948

9.  Subtype-specific suppression of Shiga toxin 2 released from Escherichia coli upon exposure to protein synthesis inhibitors.

Authors:  Malene Gantzhorn Pedersen; Claus Hansen; Erik Riise; Søren Persson; Katharina E P Olsen
Journal:  J Clin Microbiol       Date:  2008-07-23       Impact factor: 5.948

10.  Influence of RNase E deficiency on the production of stx2-bearing phages and Shiga toxin in an RNase E-inducible strain of enterohaemorrhagic Escherichia coli (EHEC) O157:H7.

Authors:  Thujitha Thuraisamy; Patricia B Lodato
Journal:  J Med Microbiol       Date:  2018-04-05       Impact factor: 2.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.